Published in Philos Trans R Soc Lond B Biol Sci on January 05, 2018
Extracellular vesicles in the tumour microenvironment. Philos Trans R Soc Lond B Biol Sci (2018) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol (2008) 19.86
5'-Triphosphate RNA is the ligand for RIG-I. Science (2006) 15.78
B lymphocytes secrete antigen-presenting vesicles. J Exp Med (1996) 11.53
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med (2012) 11.14
In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today (1990) 10.84
Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol (2013) 10.02
Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science (2008) 9.42
Shedding microvesicles: artefacts no more. Trends Cell Biol (2009) 8.84
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature (2002) 7.07
Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity (2009) 5.70
Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem (2003) 4.14
Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol (1985) 3.63
Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J Cell Biol (1997) 3.31
An emergency response team for membrane repair. Nat Rev Mol Cell Biol (2005) 3.31
Regulation of immune responses by extracellular vesicles. Nat Rev Immunol (2014) 3.24
The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res (2006) 3.22
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med (2009) 3.17
Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med (2002) 3.02
Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev (2012) 2.98
Active Wnt proteins are secreted on exosomes. Nat Cell Biol (2012) 2.81
Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods (2002) 2.77
Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res (2005) 2.72
Induction of myeloid-derived suppressor cells by tumor exosomes. Int J Cancer (2009) 2.64
Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol (2008) 2.53
Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol (2011) 2.34
ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood (2005) 2.34
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med (2005) 2.33
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med (2005) 2.26
Raft ceramide in molecular medicine. Oncogene (2003) 2.20
Biogenesis and secretion of exosomes. Curr Opin Cell Biol (2014) 2.20
Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity (2007) 2.20
Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles (2014) 2.11
Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med (2011) 2.10
Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer (2014) 2.00
Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology (2005) 2.00
Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci (2013) 1.98
Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis. Thorax (2010) 1.92
Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol (2011) 1.90
Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res (2010) 1.82
Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles (2012) 1.81
Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol (2015) 1.80
Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol (2009) 1.79
T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin Cancer Res (2003) 1.79
Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS One (2009) 1.70
Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PLoS One (2008) 1.63
Tetraspanins in extracellular vesicle formation and function. Front Immunol (2014) 1.56
Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol Dis (2005) 1.54
Sorting it out: regulation of exosome loading. Semin Cancer Biol (2014) 1.54
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology (2015) 1.53
Reversible inhibition of Hsp70 chaperone function by Scythe and Reaper. EMBO J (2001) 1.50
Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res (2010) 1.43
Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1. Haematologica (2011) 1.37
Adenosine: an endogenous modulator of innate immune system with therapeutic potential. Eur J Pharmacol (2009) 1.35
Exosomes in cancer: small particle, big player. J Hematol Oncol (2015) 1.29
Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol Chem (2003) 1.28
Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. PLoS One (2011) 1.28
Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis. Biochem Soc Trans (2011) 1.25
Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget (2014) 1.25
Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity. Blood (2013) 1.22
MHC class I down-regulation: tumour escape from immune surveillance? (review). Int J Oncol (2004) 1.20
Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions. Blood (2013) 1.19
Accessing the therapeutic potential of immunostimulatory nucleic acids. Curr Opin Immunol (2008) 1.18
MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells. Immunol Lett (2003) 1.14
B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors. Cell Mol Life Sci (2011) 1.11
Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes. Free Radic Biol Med (2007) 1.09
Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells. Cell Stress Chaperones (2003) 1.07
Dendritic cell-derived exosomes as immunotherapies in the fight against cancer. J Immunol (2014) 1.05
Death receptor-ligand systems in cancer, cell death, and inflammation. Cold Spring Harb Perspect Biol (2013) 1.03
Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γ. J Immunother (2011) 1.03
Formation and role of exosomes in cancer. Cell Mol Life Sci (2014) 1.02
Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PLoS One (2014) 0.99
Selective externalization of the transferrin receptor by sheep reticulocytes in vitro. Response to ligands and inhibitors of endocytosis. J Biol Chem (1984) 0.98
Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion. PLoS One (2014) 0.97
Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation. Semin Cancer Biol (2014) 0.96
Sequential interplay between BAG6 and HSP70 upon heat shock. Cell Mol Life Sci (2009) 0.95
Chaperon and adjuvant activity of hsp70: different natural killer requirement for cross-priming of chaperoned and bystander antigens. Cancer Res (2005) 0.95
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases. Inflamm Bowel Dis (2008) 0.94
Identification of IDO-positive and IDO-negative human dendritic cells after activation by various proinflammatory stimuli. J Immunol (2011) 0.93
Information transfer by exosomes: A new frontier in hematologic malignancies. Blood Rev (2015) 0.93
Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Sci Rep (2016) 0.91
Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p. Oncotarget (2015) 0.91
BAG-6, a jack of all trades in health and disease. Cell Mol Life Sci (2013) 0.89
γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression. FASEB J (2011) 0.86
Tumor-Derived Exosomes and Their Role in Cancer Progression. Adv Clin Chem (2016) 0.83
Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer. Oncoimmunology (2015) 0.83
Exosomes from murine-derived GL26 cells promote glioblastoma tumor growth by reducing number and function of CD8+T cells. Asian Pac J Cancer Prev (2013) 0.82
[B7-H6 : a novel alert signal for NK cells]. Med Sci (Paris) (2010) 0.80
RIG-I activation induces the release of extracellular vesicles with antitumor activity. Oncoimmunology (2016) 0.79
Tumour-derived exosomes: Tiny envelopes for big stories. Biol Cell (2015) 0.79
Glioma-derived extracellular vesicles selectively suppress immune responses. Neuro Oncol (2015) 0.79
Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes from cancer cells. Oncol Lett (2015) 0.77
Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression. Arch Immunol Ther Exp (Warsz) (2017) 0.76
Smoking-related microRNAs and mRNAs in human peripheral blood mononuclear cells. Toxicol Appl Pharmacol (2016) 0.76
Cancer testis antigen and immunotherapy. Immunotargets Ther (2013) 0.76
Extracellular vesicles released from chronic lymphocytic leukemia cells exhibit a disease relevant mRNA signature and transfer mRNAs to bystander cells. Haematologica (2016) 0.75
Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy. Sci Rep (2016) 0.75